Transcatheter Embolization and Occlusion Devices Market

Transcatheter Embolization and Occlusion Devices Market (Product - Embolization Coils, Coiling-assist Devices, Embolization Particles, Flow Diverter Devices, Liquid Embolics, Accessories; Application - Peripheral Vascular Disease, Neurology, Oncology, Urology; End user - Hospitals, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027. Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market during the forecast period.
  • According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is anticipated to expand at a CAGR of 7.8 % from 2019 to 2027. In terms of volume, the global transcatheter embolization devices were accounted at 73,92,954 units in 2018. 
fa global transcatheter embolization occlusion devices market

Increase in Spectrum of Transcatheter Embolization in Gynecologic and Obstetric Indications: Key Drivers

  • Transcatheter embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and could prevent surgery, thereby decreasing morbidity and mortality and conserving a patient’s future fertility potential.
  • Under experienced interventional radiologists and essential technical support, transcatheter embolization can be performed for the treatment of numerous lesions in the female pelvis, including obstetric-gynecologic hemorrhage, advanced-stage malignancy, ectopic pregnancy, and arteriovenous malformation. It can also be used to treat pelvic congestion syndrome and symptomatic uterine fibroids in women who have undergone appropriate screening. Global success rate of 85% and higher have been reported in women treated with embolization for uterine fibroids.

Development of New Materials for Catheterization and Embolization Boost Market Growth

  • As new materials for catheterization and embolization are developed, to provide greater vascular occlusion with regard to clinical performance and lower the complication rates. Many new agents have appeared on the market in the past several years.
  • Liquid embolic agents under investigation are primarily targeted toward the treatment of aneurysms, AVMs, and HCC. The administration of currently available liquid embolic polymers, NBCA, Onyx, and PHIL are associated with the introduction of toxic compounds. Hence, several groups are investigating new in situ gelling polymer systems that avoid the use of toxic byproducts or solvents.
  • The number of flow-directed embolic materials is expanding. The microspheres are prepared using a suspension polymerization process of poly(lactide-co-glycolide)-block-poly(ethylene glycol) crosslinker and PEGMA monomer. Co-monomers methacrylic acid (MA) and 2-methylene-1,3-dioxepane (MDO) were integrated to refine its properties.

Post Embolization Syndrome to Hamper Market

  • Embolization is a useful technique in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. Such injuries are unusual; however, the presence of hemobilia or hemoperitoneum resulting from pseudoaneurysm or laceration of a blood vessel could put a patient critically at risk. Selective embolization of the injury provides excellent results as far as hemostasis is concerned (86%), although an associated morbidity of 58% has been described, which is basically connected with bile leakage, liver abscesses, and/or necrosis. Such lesions should, therefore, be treated on an individual basis, with full awareness of the possible consequences of a technique that is not risk-free.
  • The most common complication after embolization, the cause of which is still not properly understood, is the occurrence of fever, pain in the right hypochondrium, and a rise in transaminases. High temperature (< 38.5°C) may occur between 41% and 74% of cases and seems to be related to the presence of necrosis of the tumor and healthy tissue. Cytolysis (increase in transaminases), which has been observed in up to 93% of cases, is related to damage to healthy (noncancerous) hepatocytes.

Global Transcatheter Embolization and Occlusion Devices Market: Competitive Landscape

  • This report profiles major players in the global transcatheter embolization and occlusion devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global transcatheter embolization and occlusion devices market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global transcatheter embolization and occlusion devices market are
    • BTG plc
    • Boston Scientific Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Cook Medical
    • Edwards Lifesciences Corporation
    • Merit Medical Systems
    • Johnson & Johnson Services, Inc.
    • Pfizer, Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Sirtex Medical Limited
    • Abbott Laboratories.

Global Transcatheter Embolization and Occlusion Devices Market: Key Developments

Key players in the global transcatheter embolization and occlusion devices market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global transcatheter embolization and occlusion devices market. A few expansion strategies adopted by players operating in the global transcatheter embolization and occlusion devices market are:

  • In October 2017, BTG plc announced the acquisition of Roxwood Medical, a manufacturer of advanced cardiovascular specialty catheters used in the treatment of patients with severe coronary and peripheral artery disease.
  • In October, 2017, Boston Scientific Corporation completed the acquisition of Apama Medical Inc. (Apama), a privately-held company developing the Apama Radiofrequency single-shot Balloon Catheter System for the treatment of atrial fibrillation.
  • In January 2017, Ethicon Endo-Surgery, Inc., a subsidiary of Johnson and Johnson, announced the acquisition of Megadyne Medical Products, Inc., a privately-held medical devices company that develops, manufactures, and markets electrosurgical tools used in operating rooms across the globe.

The report on the global transcatheter embolization and occlusion devices market discussed individual strategies, followed by company profiles of manufacturers of transcatheter embolization and occlusion devices. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global transcatheter embolization and occlusion devices market.

Frequently Asked Questions

What is the total market worth of transcatheter embolization and occlusion devices market?

The global transcatheter embolization and occlusion devices market was worth US$ 2,957.4 Mn and is projected to reach a value of US$ 5,799.8 Mn by the end of 2027

What is the anticipated CAGR of the transcatheter embolization and occlusion devices market in the forecast period?

Transcatheter embolization and occlusion devices market is anticipated to grow at a CAGR of 7.8% during the forecast period

Which region is expected to project the highest market share in the global transcatheter embolization and occlusion devices market?

North America accounted for a major share of the global transcatheter embolization and occlusion devices market

What are the key driving factors for the growth of the transcatheter embolization and occlusion devices market?

Transcatheter embolization and occlusion devices market is driven by increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases

Who are the key players in the global transcatheter embolization and occlusion devices market?

Key players in the global transcatheter embolization and occlusion devices market include BTG plc, Boston Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, and Abbott Laboratories

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transcatheter Embolization and Occlusion Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Transcatheter Embolization and Occlusion Devices Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue (US$ Mn) and Volume (Units), Projection

5. Key Insights

6. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        6.2.1. Embolization Coils

            6.2.1.1. Pushable

            6.2.1.2. Detachable

        6.2.2. Coiling-assist Devices

            6.2.2.1. Stent-assisted Coiling

            6.2.2.2. Balloon-assisted Coiling

        6.2.3. Embolization Particles

            6.2.3.1. Radioembolization Particles

            6.2.3.2. Microspheres

            6.2.3.3. Drug-eluting Beads

            6.2.3.4. Others

        6.2.4. Flow-diverting Devices

        6.2.5. Liquid Embolics

        6.2.6. Accessories

            6.2.6.1. Catheters

            6.2.6.2. Guide wires

            6.2.6.3. Others

    6.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product

7. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by Application, 2017–2027

        7.2.1. Peripheral Vascular Disease

        7.2.2. Neurology

        7.2.3. Oncology

        7.2.4. Urology

        7.2.5. Others

    7.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application

8. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by End-user, 2017–2027

        8.2.1. Hospitals

        8.2.2. Ambulatory Surgical Centers

        8.2.3. Clinics

    8.3. Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user

9. Global Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Transcatheter Embolization and Occlusion Devices Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Region

10. North America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        10.2.1. Embolization Coils

            10.2.1.1. Pushable

            10.2.1.2. Detachable

        10.2.2. Coiling-assist Devices

            10.2.2.1. Stent-assisted Coiling

            10.2.2.2. Balloon-assisted Coiling

        10.2.3. Embolization Particles

            10.2.3.1. Radioembolization Particles

            10.2.3.2. Microspheres

            10.2.3.3. Drug-eluting Beads

            10.2.3.4. Others

        10.2.4. Flow-diverting Devices

        10.2.5. Liquid Embolics

        10.2.6. Accessories

            10.2.6.1. Catheters

            10.2.6.2. Guide wires

            10.2.6.3. Others

    10.3. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.3.1. Peripheral Vascular Disease

        10.3.2. Neurology

        10.3.3. Oncology

        10.3.4. Urology

        10.3.5. Others

    10.4. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Clinics

    10.5. North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        11.2.1. Embolization Coils

            11.2.1.1. Pushable

            11.2.1.2. Detachable

        11.2.2. Coiling-assist Devices

            11.2.2.1. Stent-assisted Coiling

            11.2.2.2. Balloon-assisted Coiling

        11.2.3. Embolization Particles

            11.2.3.1. Radioembolization Particles

            11.2.3.2. Microspheres

            11.2.3.3. Drug-eluting Beads

            11.2.3.4. Others

        11.2.4. Flow-diverting Devices

        11.2.5. Liquid Embolics

        11.2.6. Accessories

            11.2.6.1. Catheters

            11.2.6.2. Guide wires

            11.2.6.3. Others

    11.3. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.3.1. Peripheral Vascular Disease

        11.3.2. Neurology

        11.3.3. Oncology

        11.3.4. Urology

        11.3.5. Others

    11.4. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Ambulatory Surgical Centers

        11.4.3. Clinics

    11.5. Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. Rest of Europe 

    11.6. Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        12.2.1. Embolization Coils

            12.2.1.1. Pushable

            12.2.1.2. Detachable

        12.2.2. Coiling-assist Devices

            12.2.2.1. Stent-assisted Coiling

            12.2.2.2. Balloon-assisted Coiling

        12.2.3. Embolization Particles

            12.2.3.1. Radioembolization Particles

            12.2.3.2. Microspheres

            12.2.3.3. Drug-eluting Beads

            12.2.3.4. Others

        12.2.4. Flow-diverting Devices

        12.2.5. Liquid Embolics

        12.2.6. Accessories

            12.2.6.1. Catheters

            12.2.6.2. Guide wires

            12.2.6.3. Others

    12.3. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.3.1. Peripheral Vascular Disease

        12.3.2. Neurology

        12.3.3. Oncology

        12.3.4. Urology

        12.3.5. Others

    12.4. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Ambulatory Surgical Centers

        12.4.3. Clinics

    12.5. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia 

        12.5.5. Rest of Asia Pacific 

    12.6. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        13.2.1. Embolization Coils

            13.2.1.1. Pushable

            13.2.1.2. Detachable

        13.2.2. Coiling-assist Devices

            13.2.2.1. Stent-assisted Coiling

            13.2.2.2. Balloon-assisted Coiling

        13.2.3. Embolization Particles

            13.2.3.1. Radioembolization Particles

            13.2.3.2. Microspheres

            13.2.3.3. Drug-eluting Beads

            13.2.3.4. Others

        13.2.4. Flow-diverting Devices

        13.2.5. Liquid Embolics

        13.2.6. Accessories

            13.2.6.1. Catheters

            13.2.6.2. Guide wires

            13.2.6.3. Others

    13.3. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.3.1. Peripheral Vascular Disease

        13.3.2. Neurology

        13.3.3. Oncology

        13.3.4. Urology

        13.3.5. Others

    13.4. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Clinics

    13.5. Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America Latin America 

    13.6. Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2027

        14.2.1. Embolization Coils

            14.2.1.1. Pushable

            14.2.1.2. Detachable

        14.2.2. Coiling-assist Devices

            14.2.2.1. Stent-assisted Coiling

            14.2.2.2. Balloon-assisted Coiling

        14.2.3. Embolization Particles

            14.2.3.1. Radioembolization Particles

            14.2.3.2. Microspheres

            14.2.3.3. Drug-eluting Beads

            14.2.3.4. Others

        14.2.4. Flow-diverting Devices

        14.2.5. Liquid Embolics

        14.2.6. Accessories

            14.2.6.1. Catheters

            14.2.6.2. Guide wires

            14.2.6.3. Others

    14.3. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

        14.3.1. Peripheral Vascular Disease

        14.3.2. Neurology

        14.3.3. Oncology

        14.3.4. Urology

        14.3.5. Others

    14.4. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Ambulatory Surgical Centers

        14.4.3. Clinics

    14.5. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Country/Sub-region, 2017–2027

        14.5.1. UAE

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa 

    14.6. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis 

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of companies)

    15.2. Competitive Market Ranking, by Company, 2018

    15.3. Company Profiles

        15.3.1. BTG plc

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. Boston Scientific Corporation 

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis

        15.3.3. Medtronic Plc 

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis

        15.3.4. Penumbra, Inc. 

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis

        15.3.5. Cook Medical

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis

        15.3.6. Edwards Lifesciences Corporation 

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis 

        15.3.7. Merit Medical Systems 

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis

        15.3.8. Johnson & Johnson Services, Inc. 

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

        15.3.9. Pfizer, Inc.

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis

        15.3.10. Stryker Corporation 

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis

        15.3.11. Terumo Corporation

            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Growth Strategies

            15.3.11.3. SWOT Analysis

        15.3.12. Sirtex Medical Limited 

            15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.12.2. Growth Strategies

            15.3.12.3. SWOT Analysis

        15.3.13. Abbott Laboratories 

            15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.13.2. Growth Strategies

            15.3.13.3. SWOT Analysis

List of Tables

Table 01: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 03: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 04: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling-assist Devices, 2017–2027

Table 05: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 06: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 07: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

Table 09: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast, by Region, 2017–2027

Table 10: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 12: North America Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 13: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 14: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

Table 15: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 16: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 17: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 21: Europe Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 22: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 23: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

Table 24: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 25: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 26: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 27: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 28: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 29: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 30: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 31: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 32: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling-assist Devices, 2017–2027

Table 33: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 34: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 35: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 36: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 37: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 38: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 39: Latin America Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 40: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 41: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

Table 42: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 43: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 44: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 45: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 46: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 47: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 48: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Volume (Units) Forecast, by Product, 2017–2027

Table 49: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Coils, 2017–2027

Table 50: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Coiling Assist Devices, 2017–2027

Table 51: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Embolization Particles, 2017–2027

Table 52: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, by Accessories, 2017–2027

Table 53: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 54: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figure

Figure 01: Global Transcatheter Embolization and Occlusion Devices Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Product (2018)

Figure 03: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Application (2018)

Figure 04: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by End-user (2018)

Figure 05: Global Transcatheter Embolization and Occlusion Devices Market Value Share, by Region (2018)

Figure 06: Global Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) and Volume (Units) Forecast, 2017–2027

Figure 07: Global Transcatheter Embolization and Occlusion Devices Market Value Share Analysis, by Product, 2018 and 2027

Figure 08: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Embolization Coils, 2017–2027

Figure 09: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Coiling-assist Devices, 2017–2027

Figure 10: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Embolization Particles, 2017–2027

Figure 11: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Flow Diverter Devices, 2017–2027

Figure 12: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Liquid Embolics, 2017–2027

Figure 13: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Accessories, 2017–2027

Figure 14: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Pushable, 2017–2027

Figure 15: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Detachable, 2017–2027

Figure 16: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Stent-assisted Coiling, 2017–2027

Figure 17: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Balloon-assisted Coiling, 2017–2027

Figure 18: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Radioembolization Particles, 2017–2027

Figure 19: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Microspheres, 2017–2027

Figure 20: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Drug-eluting Beads, 2017–2027

Figure 21: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Others, 2017–2027

Figure 22: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Catheters, 2017–2027

Figure 23: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Guide Wires, 2017–2027

Figure 24: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) and Volume (Units), by Others, 2017–2027

Figure 25: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis, by Product, 2018–2026

Figure 26: Global Transcatheter Embolization and Occlusion Devices Market Value Share Analysis, by Application, 2018 and 2027

Figure 27: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Vascular Disease, 2017–2027

Figure 28: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Neurology, by 2017–2027

Figure 29: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Oncology, by 2017–2027

Figure 30: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Urology, by 2017–2027

Figure 31: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, Others, by 2017–2027

Figure 32: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness Analysis, by Application, 2018–2026

Figure 33: Global Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 34: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

Figure 35: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers (ASCs), 2017–2027

Figure 36: Global Transcatheter Embolization and Occlusion Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinics, 2017–2027

Figure 37: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 38: Global Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Region, 2018 and 2026

Figure 39: Global Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Region, 2018–2026

Figure 40: North America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 41: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country, 2018 and 2027

Figure 42: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country, 2018–2026

Figure 43: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

Figure 44: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

Figure 45: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

Figure 46: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

Figure 47: North America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 48: North America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 49: Europe Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country, 2018 and 2027

Figure 51: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 52: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

Figure 53: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

Figure 54: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

Figure 55: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

Figure 56: Europe Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 57: Europe Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 58: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 59: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 60: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 61: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

Figure 62: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

Figure 63: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

Figure 64: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

Figure 65: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 66: Asia Pacific Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 67: Latin America Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 68: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/sub-region, 2018 and 2027

Figure 69: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/sub-region, 2018–2026

Figure 70: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

Figure 71: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

Figure 72: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

Figure 73: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

Figure 74: Latin America Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 75: Latin America Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 76: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 77: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 78: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 79: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Product, 2018 and 2027

Figure 80: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Product, 2018–2026

Figure 81: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by Application, 2018 and 2027

Figure 82: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by Application, 2018–2026

Figure 83: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 84: Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Attractiveness, by End-user, 2018–2026

Figure 85: Global Transcatheter Embolization and Occlusion Devices Market Analysis, by Top Company Ranking, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved